- Home
- Equipment
- south korea
- clinic celiacshield trial
Show results for
Refine by
Clinic Celiacshield Trial Equipment Supplied In South Korea
15 equipment items found
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
A randomized, double-blind, placebo-controlled, single and repeated dose, escalation clinical trial to evaluate the safety, tolerability, and pharmacokinetics of VVZ-149 injection in healthy adult ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
Single-dose, escalation clinical trial to evaluate the safety and pharmacokinetics of VVZ-149 injection in healthy elderly ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
A randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the analgesic efficacy and safety of VVZ-149 Injection in patients who have pain after laparoscopic and robotic-laparoscopic ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
A multicenter, randomized, double-blind, parallel-group, placebo-controlled phase 3 clinical trial to evaluate the analgesic efficacy and safety of VVZ-149 injection in patients who have pain after laparoscopic ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
A randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the analgesic efficacy and safety of VVZ-149 Injection in patients who have pain after laparoscopic gastrectomy in early gastric cancer ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
A randomized, double-blind, parallel group, placebo-controlled clinical trial to evaluate the analgesic efficacy and safety of VVZ-149 Injection in patients who have pain after artificial hip replacement ...
Manufactured by:INTIN Inc. based inDaegu, SOUTH KOREA
A simple sperm test you can use at home. Check the number and motility of your sperm based on WHO ...
Manufactured by:JNBIO based inChuncheon-si, SOUTH KOREA
SPIRO PICO is ideal for monitoring respiratory and in the self management of Asthma, COPD, and for use in Clinical ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
On July 29, 2020, Vivozon applied for a patent for a second pipeline, VVZ-2471, and is currently conducting non-clinical toxicity studies. VVZ-2471 is a new drug candidate for treating chronic pain including neuropathic pain. Recently, the prevention and treatment potential of drug (morphine) addiction, anxiety, and depression have also been demonstrated through non-clinical studies. ...
Manufactured by:PharmAbcine Inc. based inYuseong-gu, SOUTH KOREA
Olinvacimab is an anti-angiogenic antibody that neutralizes the VEGF/VEGFR2 pathway, thus inhibiting tumor growth and ...
Manufactured by:INTIN Inc. based inDaegu, SOUTH KOREA
Ovulation Tester: The Oview Ovulation Tester, which uses saliva, checks ovulation date with a drop of saliva anytime, anywhere. When a woman ovulates, 'bracken-shape' crystal structure can be identified in the dried saliva due to the secretion of estrogen ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
WX presents biomarkers, based on raw transcriptome data. It is an artificial intelligence technology that can predict biomarkers, prognostic biomarkers and even the mode of action (MOA) of disease ...
by:Vivozon Inc. based inYongin-si, SOUTH KOREA
Opiranserin (VVZ-149) for injection is a first-in-class non-narcotic analgesic under development by Vivozon. As atreatment for postoperative pain used as a first-line therapy in the global market, Opiranserin aims to ultimately replaceopioid analgesics by providing an effective and safe solution for pain management. With the hope to combat opioidmisuse and abuse, Opiranserin is currently ...
Manufactured by:MitoImmune Therapeutics Inc. based inGangnam-gu, SOUTH KOREA
MIT-001 is expected to meet the medical need for oral mucositis for which there is no cure. It aims to be a first-in-class drug that can be used by both patients with head and neck cancer or hematological cancer with a high incidence and severity of oral mucositis as a side effect of chemoradiation ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Tissue specimens are either from surgical resections or biopsies which may raise the risk of bleeding, and infection and further require recovery from the procedure. Genomic profiling of tissue samples provides a single point in space and time which is lacking the ability to reveal tumor heterogeneity and to test repeatedly to monitor the treatment efficacy. The risk of tissue biopsy is much ...